STAGE III SOFT TISSUE SARCOMA AJCC V7
Clinical trials for STAGE III SOFT TISSUE SARCOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SOFT TISSUE SARCOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III SOFT TISSUE SARCOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: targeted pill shows promise in Gene-Matched tumors
Disease control CompletedThis study tested a drug called tazemetostat in 20 children and teens whose cancers had come back or didn't respond to treatment. Only those with specific gene changes (EZH2, SMARCB1, or SMARCA4) in their tumors were included. The goal was to see if the drug could shrink tumors o…
Matched conditions: STAGE III SOFT TISSUE SARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
New drug shows promise for kids with recurrent cancers
Disease control CompletedThis study tested a drug called samotolisib in 18 children whose cancers had come back or didn't respond to treatment. The children had specific gene changes in their tumors. The goal was to see if the drug could shrink or stop the cancer. The study was completed, but results are…
Matched conditions: STAGE III SOFT TISSUE SARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC